Inflammatory bio‐markers and cardiovascular risk prediction

  title={Inflammatory bio‐markers and cardiovascular risk prediction},
  author={Gavin J. Blake and Paul M. Ridker},
  journal={Journal of Internal Medicine},
Abstract. Blake GJ, Ridker PM (Harvard Medical School, Boston, MA, USA). Inflammatory bio‐markers and cardiovascular risk prediction (Review). J Intern Med 2002; 252: 283–294. 
Biomarkers of Inflammation and Malnutrition Associated with Early Death in Healthy Elderly People
Whether malnutrition and biomarkers of inflammation predict all‐cause, cancer, and cardiovascular mortality in healthy elderly subjects is studied.
Advances in cardiac biomarkers.
Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels
Objective  Although androgen replacement has been shown to have beneficial effects in hypogonadal men, there is concern that androgens may deleteriously affect cardiovascular risk in elderly men.
Raised CRP Levels in Obese Patients: Symptoms of Depression Have an Independent Positive Association
Background: Depression and obesity, the two common ailments of modern society, are associated with increased risk of coronary artery disease and raised C‐reactive protein (CRP) levels. Are the
The effect of fish oil on inflammation markers in adult patients undergoing hemodialysis: A meta‐analysis
This meta‐analysis was to assess the effect of fish oil supplementation on inflammation markers in adult patients receiving hemodialysis and found no significant difference between fish oil and placebo levels.
Periodontal, metabolic, and cardiovascular disease: Exploring the role of inflammation and mental health
Future longitudinal studies should focus on reciprocal interactions and cascading effects, as well as points for effective preventative and therapeutic interventions across diagnostic domains to reduce morbidity, mortality and improve quality of life.
Inflammation, platelet aggregation and prognosis in acute myocardial infarction
The incidence of stroke and re-infarction is noticeably high in the first few days following acute myocardial infarction. This finding has raised questions whether the systemic inflammatory reactio
Markers of endothelial cell activation in elderly men at high risk for coronary heart disease
The present results may contribute to the understanding of the multitude of factors influencing these endothelial markers and their evaluation in various disease entities.
Inflammatory markers and the risk of coronary heart disease in men and women.
Although plasma lipid levels were more strongly associated with an increased risk than were inflammatory markers, the level of C-reactive protein remained a significant contributor to the prediction of coronary heart disease.
C‐reactive protein, interleukin‐6, secretory phospholipase A2 group IIA and intercellular adhesion molecule‐1 in the prediction of late outcome events after acute coronary syndromes
Levels of C‐reactive protein (CRP), interleukin‐6 (IL‐6), secretory phospholipase A2 group IIA (sPLA2‐IIA) and intercellular adhesion molecule‐1 (ICAM‐I) predict late outcomes in patients with acute coronary syndromes (ACS).


C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying persons at risk for cardiovascular events.
Are statins anti-inflammatory?
Emerging evidence from both clinical trials and basic science studies suggest that statins have anti-inflammatory properties, which may additionally lead to clinical efficacy and measurement of markers of inflammation such as high sensitivity C-reactive protein in addition to lipid parameters may help identify those patients who will benefit most from statin therapy.
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
In this prospective trial, pravastatin reduced CRP levels at both 12 and 24 weeks in a largely LDL-C-independent manner, providing evidence that statins may have anti-inflammatory effects in addition to lipid-lowering effects.
Association of C-reactive protein with markers of prevalent atherosclerotic disease.
Blood Pressure and Inflammation in Apparently Healthy Men
The data suggest that increased blood pressure may be a stimulus for inflammation and that this is a possible mechanism underlying the well-established role of hypertension as a risk factor for atherosclerotic disease.
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Findings suggest that some inflammatory processes, unrelated to the chronic infections studied here, are likely to be involved in coronary heart disease.
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.
BACKGROUND Coronary heart disease remains the leading cause of morbidity and mortality in the industrialized world. Clinical and laboratory studies have shown that inflammation plays a major role in
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.
It is shown that CRP was associated with incident events in the elderly, especially in those with subclinical disease at baseline, and in women but not men, the mean CRP level was higher for case subjects than for control subjects.
Novel clinical markers of vascular wall inflammation.
The addition of CRP screening to traditional lipid testing has the potential to identify individuals at high risk for future cardiovascular events who may benefit from targeted preventive interventions.